Complete Response of a Patient With a Mismatch Repair Deficient Aggressive Pituitary Adenoma to Immune Checkpoint Inhibitor Therapy: A Case Report-Reference-Cited by-同舟云学术

Complete Response of a Patient With a Mismatch Repair Deficient Aggressive Pituitary Adenoma to Immune Checkpoint Inhibitor Therapy: A Case Report

Published:2022-05-13 Issue:2 Volume:91 Page:e51-e56
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:

Author:

Shah Sanjit,Manzoor Saima,Rothman Yehudit,Hagen Matthew,Pater Luke,Golnik Karl,Mahammedi Abdelkader,Lin Andrew L.,Bhabhra Ruchi,Forbes Jonathan A.,Sengupta Soma

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Reference30 articles.

1. Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016;McCormack;Eur J Endocrinol.,2018

2. Long-term survival with ACTH-secreting carcinoma of the pituitary: a case report and review of the literature;Landman;J Clin Endocrinol Metab.,2002

3. Pathology of invasive pituitary tumors with special reference to functional classification;Scheithauer;J Neurosurg.,1986

4. The treatment of refractory pituitary adenomas;Dai;Front Endocrinol (Lausanne).,2019

5. Definition and diagnosis of aggressive pituitary tumors;Kasuki;Rev Endocr Metab Disord.,2020

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutical Usefulness of PD-1/PD-L1 Inhibitors in Aggressive or Metastatic Pituitary Tumours;Cancers;2024-08-30

2. Immune landscape and progress in immunotherapy for pituitary neuroendocrine tumors;Cancer Letters;2024-06

3. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors;Acta Neuropathologica;2024-05-17

4. Immunotherapy for endocrine tumours: a clinician’s perspective;Endocrine-Related Cancer;2024-01-18

5. The Role of Programmed Cell Death Ligand 1 Expression in Pituitary Tumours: Lessons from the Current Literature;Neuroendocrinology;2024